Evidence map›Paper›PMID 30550590›Full record

ArticlePloS one2018

Glandular defects in the mouse uterus with sustained activation of TGF-beta signaling is associated with altered differentiation of endometrial stromal cells and formation of stromal compartment.

Nan Ni, Yang Gao, Xin Fang, Maria Melgar, David F Vincent, John P Lydon, Laurent Bartholin, Qinglei Li

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Disruption of primary ciliary prostaglandin EJournal of biomedical science · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Nan NiDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Yang GaoDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Xin FangDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
Maria MelgarDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.
David F VincentCancer Research United Kingdom Beatson Institute, Garscube Estate, Glasgow, United Kingdom.
John P LydonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Laurent BartholinCentre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre Léon Bérard, Lyon, France.
Qinglei LiDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, United States of America.ORCID 0000-0002-4515-7963
Texas A&M University · USBaylor College of Medicine · USCancer Research UK Scotland Institute · GBUniversité Claude Bernard Lyon 1 · FR

Funding

TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTIONR01HD087236 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2017 to 2021
$1.5M
Characterization of a novel mouse model with enhanced TGF-Beta signaling in the ovaryR03HD082416 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2015 to 2016
$141k
NICHD NIH HHS R01 HD087236NICHD NIH HHS R03 HD082416
6 · The paper itself

Abstract

Uterine gland development, also known as adenogenesis, is a key uterine morphogenic process indispensable for normal uterine function and fertility. Our earlier studies have reported that overactivation of TGFB receptor 1 (TGFBR1) in the mouse uterus using progesterone receptor (Pgr)-Cre recombinase causes female infertility, defective decidualization, and reduced uterine gland formation, a developmental milestone of postnatal uterus. To understand mechanisms that underpin the disrupted uterine gland formation in mice with sustained activation of TGFBR1, we raised the question of whether early postnatal adenogenesis was compromised in these mice. Experiments were designed using mice with constitutive activation of TGFBR1 driven by Pgr-Cre to determine the timing of adenogenic defects and potential mechanisms associated with dysregulation of adenogenic genes, luminal epithelial cell proliferation and endometrial fibrotic changes. Uterine tissues from mice with constitutive activation of TGFBR1 were collected during the critical time window of adenogenesis and analyzed together with age-matched controls. Multiple approaches including immunohistochemistry, immunofluorescence, Trichrome staining, quantitative real-time PCR, western blot, conditional knockout and human endometrial cell culture were utilized. TGFBR1 activation in the mouse uterus suppressed adenogenesis during postnatal uterine development, concomitant with the aberrant differentiation of uterine stromal cells. Analysis of transcript expression of WNT pathway components revealed dysregulation of adenogenesis-associated genes. Notably, the adenogenic defects occurred in spite of the increased proliferation of uterine luminal epithelial cells, accompanied by increased expression of genes associated with fibrotic changes. Moreover, the adenogenic defects were alleviated in mice where TGFBR1 was activated in presumably half of the complement of uterine cells. Our results suggest that altered differentiation of endometrial stromal cells and formation of stromal compartment promote adenogenic defects.

Indexed as

AnimalsCell DifferentiationCell LineEpithelial CellsFemaleHumansInfertility, FemaleMiceMice, TransgenicOrganogenesisReceptors, ProgesteroneReceptor, Transforming Growth Factor-beta Type ISignal TransductionStromal CellsTransforming Growth Factor betaUterusReceptors, ProgesteroneReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouseTransforming Growth Factor beta

Identifiers

PMID30550590
PMCPMC6294433
OpenAlexW2905280724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.